HPGD
protein-coding15-hydroxyprostaglandin dehydrogenase, the group of Short chain dehydrogenase/reductase superfamily
Gene summary
This gene encodes a member of the short-chain nonmetalloenzyme alcohol dehydrogenase protein family. The encoded enzyme is responsible for the metabolism of prostaglandins, which function in a variety of physiologic and cellular processes such as inflammation. Mutations in this gene result in primary autosomal recessive hypertrophic osteoarthropathy and cranioosteoarthropathy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~33.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0007343
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0024546
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0024546
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009799
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0015466
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0024546
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0007343
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007343
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0016620
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0024546
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: Musculoskeletal
Rationale: Medical treatment (eg, with sulfasalazine, methotrexate) has been described as beneficial related to joint manifestations
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HPGD variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000860.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 17 | 3 | 23 | ||
| missense | 2 | 4 | 62 | 3 | 1 | 72 |
| nonsense | 3 | 2 | 5 | |||
| start loss | 2 | 2 | ||||
| frameshift | 7 | 2 | 9 | |||
| splice donor/acceptor (+/-2bp) | 8 | 2 | 10 | |||
| Total | 22 | 8 | 67 | 20 | 4 | 121 |
Highest pathogenic variant AF is 0.00019764437
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000851.2 | 7 | MANE Select | |
| Ensembl | ENSP00000296522.6 | 7 | MANE Select | |
| RefSeq | NP_001139288.1 | 6 | Standard | |
| RefSeq | NP_001243230.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Transcriptional misregulation in cancer - Homo sapiens (human)
- Prostaglandin Synthesis and Regulation
- Metabolism of lipids
- Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
- Arachidonic acid metabolism
Biological Process
- kidney development
- prostaglandin metabolic process
- transforming growth factor beta receptor signaling pathway
- female pregnancy
- parturition
Molecular Function
- catalytic activity
- prostaglandin E receptor activity
- 15-hydroxyprostaglandin dehydrogenase (NAD+) activity
- protein homodimerization activity
- NAD binding
Cellular Component
- nucleoplasm
- cytoplasm
- cytosol
- basolateral plasma membrane
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000296522
- Coding exons
- 7
- Length
- 32978
- Individuals with no LoFs
- 125661
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 87
- Defined
- 125748
- p
- 0.000346
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.119 | 145 | 141 | 1.03 | 0.00000657 | 1740 |
| Missense (PolyPhen) | 55 | 56.309 | 0.97675 | 646 | ||
| Synonymous | 1.01 | 41 | 50.1 | 0.819 | 0.00000244 | 493 |
| Loss of Function | 0.930 | 9 | 12.6 | 0.717 | 5.28e-7 | 165 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0011 | 0.0011 | notable |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00048 | 0.00047 | rare |
| South Asian | 0.000099 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. Inhibits in vivo proliferation of colon cancer cells. {ECO:0000269|PubMed:10837478, ECO:0000269|PubMed:15574495, ECO:0000269|PubMed:16828555}.;
- Disease
- DISEASE: Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 (PHOAR1) [MIM:259100]: A disease characterized by digital clubbing, periostosis, acroosteolysis, painful joint enlargement, and variable features of pachydermia that include thickened facial skin and a thickened scalp. Other developmental anomalies include delayed closure of the cranial sutures and congenital heart disease. {ECO:0000269|PubMed:18500342}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cranioosteoarthropathy (COA) [MIM:259100]: A form of osteoarthropathy characterized by swelling of the joints, digital clubbing, hyperhidrosis, delayed closure of the fontanels, periostosis, and variable patent ductus arteriosus. Pachydermia is not a prominent feature. {ECO:0000269|PubMed:18500342}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Isolated congenital nail clubbing (ICNC) [MIM:119900]: A rare genodermatosis characterized by enlargement of the nail plate and terminal segments of the fingers and toes, resulting from proliferation of the connective tissues between the nail matrix and the distal phalanx. It is usually symmetrical and bilateral (in some cases unilateral). In nail clubbing usually the distal end of the nail matrix is relatively high compared to the proximal end, while the nail plate is complete but its dimensions and diameter more or less vary in comparison to normal. There may be different fingers and toes involved to varying degrees. Some fingers or toes are spared, but the thumbs are almost always involved. {ECO:0000269|PubMed:18805827}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- LoFtool
- 0.311
- RVIS EVS
- -0.21
- RVIS percentile EVS
- 38.58
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.164
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |